May 24, 2025, 23:50

Solid Tumors Oncology Programme – Hôpital Riviera-Chablais, Rennaz, Switzerland

Hôpital Riviera-Chablais (HRC) serves the Riviera and Chablais regions of Switzerland, with a patient base of 180,000 and a multidisciplinary healthcare team of over 2,000 employees. The hospital provides a full spectrum of medical services including outpatient care, emergency medicine, acute and chronic inpatient services, and rehabilitation.

Established in July 2020, the Medical Oncology Service at HRC delivers state-of-the-art care and performs approximately 14,000 consultations annually. Oncology patients benefit from an integrated approach via the Oncology Pole, which consolidates medical oncology, radiotherapy, diagnostics, and specialty consults under one collaborative umbrella. Weekly multidisciplinary tumor boards ensure precision-driven, personalized cancer care.

Programme Mentors:

Dr Emanuela Salati
Dr Ana Durigova
Dr Roma Malval
Dr Asteria Nikolopoulou

Type:

Visiting Observership
Visiting Residency

Duration: 3–6 months

Language Requirements:

Candidates must have at least an intermediate level of French, as interviews and clinical activities are conducted in French.

Programme Description:

Participants will spend three months rotating through the oncology department, observing clinical activities in breast, gastrointestinal, lung, gynecological, head and neck, and general oncology outpatient clinics. The program offers hands-on exposure to:

Day-to-day clinical practice alongside HRC oncologists
Multidisciplinary tumor boards and decision-making frameworks
Organization and administration of oncology patient management
Collaborative care pathways within the Oncology Pole

The experience provides valuable insight into Swiss oncology practice, multidisciplinary cancer care, and the integration of technical innovation in clinical workflows.

Breast Cancer cancer GI oncology Gynecologic Oncology H&N oncology Hôpital Riviera-Chablais Lung cancer medical oncology multidisciplinary care OncoDaily Oncology solid tumors Swiss Oncology visiting observership visiting residency

Douglas Flora: Fighting Cancer with Heart

Eric Small: Deeply Honored to Step Into the Role of 2025-26 ASCO President

Cyril Konto: I Trademarked The Word ‘Multispecific’ The Day I Arrived

Levi Garraway: Transforming Oncology Through Precision, Resilience And Heart

20 Posts Not to Miss from ASCO 2025